Published: 30 December 2022 Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease Contributors: Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko, Victor Pashkov, [...]
We need donors that are 18 and older to establish the ranges for a new assay to detect 65 cytokines from serum samples. The assay is one of a kind [...]
Ayass BioScience, LLC participated in Annual Meeting of The American Association of Immunologists in Oregon Convention Center Portland, Oregon, May 6-10 2022.
The Ayass Bioscience family is celebrating its sixth anniversary this year. The company has grown over the years from the dreams of our founder and CEO, Dr. Ayass, into one [...]
Testing for COVID-19 has gone up significantly in the last month, and consequently positive cases have risen as well and more Omicron variants were identified at our laboratory. Given the [...]
The Texas State Health Department has confirmed the findings of a Ayass BioScience, LLC laboratory that detected two North Texas cases of the omicron variant.
Ayass BioScience, LLC has detected the first two cases of the OMICRON variant in the DFW Metroplex using Next Generation Sequencing (NGS). This is a part of our [...]
Dr. Ayass and Mass Spectrometry Scientist Wanying Cao, Ph.D. in front of "Nasopharyngeal Proteomic Findings in COVID-19 " Poster at the Annual 69th ASMS Conference on Mass Spectrometry.
Physician-scientists have changed the history of medicine by identifying problems in the clinic and taking to the laboratory to solve them. The founder of our company, Dr. Ayass, is revolutionizing [...]
National Doctors’ Day was over the weekend. Thank you to all physicians around the world for providing their patients with the highest-quality care and compassion when it's most needed. We [...]
